Neurofeedback for episodic migraine
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether neurofeedback, a technique that helps you control your brain activity, can reduce the frequency of migraine attacks in people with episodic migraine. If you have 5 to 14 migraine days per month, this study might help you manage your migraines without medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with episodic migraine (migraine attacks on 5 to 14 days per month) for at least the last 3 months.
- You do not have chronic migraine (defined as 15 or more headache days per month).
- You have not had a severe psychiatric condition requiring treatment in the last 6 months.
- You have no history of brain injury or neurological condition that would make neurofeedback unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether chiropractic adjustments (spinal manipulation) can help reduce the number of migraine days you have each month. You will be randomly assigned to one of two groups: one group gets chiropractic care plus usual care, the other gets a sham (fake) treatment plus usual care, so researchers can see if the real adjustments work better.
This trial looks at the chemical changes in the blood of people with migraine. It aims to better understand the disease and may help find new treatments. You may qualify if you have episodic or chronic migraine and have not tried CGRP-targeting drugs.
This study tests whether learning mindfulness (focused attention and relaxation) through a virtual reality headset can help reduce migraine frequency and severity. You'll use the VR program at home while continuing your current migraine medication.
This Phase 3 study tests eptinezumab to reduce migraine attacks in children who have episodic migraine (not daily chronic migraine). It may help by lowering the number of headache days and migraine days over time. You must complete a headache diary during screening to be considered.
This trial tests if Xeomin injections can help prevent episodic migraines in people who have 6 to 14 migraine days per month. It's for those under 50 when their migraines started and who can tell migraine from other headaches.
This trial is testing new approaches for people whose migraines haven't improved with multiple preventive treatments. The goal is to find better options for those with hard-to-treat migraine.
Hear when a new Episodic Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.